-
1.
公开(公告)号:US12128128B2
公开(公告)日:2024-10-29
申请号:US16499406
申请日:2018-03-29
申请人: Phyto Sophos Ltd.
发明人: Laura Dewar
IPC分类号: A61K8/9789 , A61K8/02 , A61K8/19 , A61K8/9741 , A61K8/9755 , A61K8/9783 , A61K8/9794 , A61K9/00 , A61K33/38 , A61K36/11 , A61K36/14 , A61K36/185 , A61K36/25 , A61K36/258 , A61K36/28 , A61K36/29 , A61K36/30 , A61K36/36 , A61K36/38 , A61K36/48 , A61K36/66 , A61K36/70 , A61K36/74 , A61K36/886 , A61L26/00 , A61P17/02 , A61Q19/00
CPC分类号: A61K8/9789 , A61K8/0208 , A61K8/19 , A61K8/9794 , A61Q19/00
摘要: In one aspect, a composition for topical application is provided. The composition comprises a base. Dispersed within the base is elemental silver as a colloidal suspension, and plant extract from at least 6 plants. The plants are selected from the group consisting of Echinacea purpurea, Stellaria media, Aloe vera, Matricaria recutita, Hypericum perforatum, Calendula officinalis, Equisetum arvense, Symphytum officinale, Panax ginseng, Rumex crispus, Arctium lappa, Trifolium pratense, Chelidonium majus, Thuja occidentalis, Urtica dioica, Mahonia aquifolium, and Galium aparine.
-
公开(公告)号:US20240299464A1
公开(公告)日:2024-09-12
申请号:US18443193
申请日:2024-02-15
申请人: Minh H. Nguyen
发明人: Minh H. Nguyen
IPC分类号: A61K35/644 , A61K36/258 , A61K36/537 , A61K36/67 , A61K36/899 , A61K36/9068 , A61P25/22 , A61P37/04
CPC分类号: A61K35/644 , A61K36/258 , A61K36/537 , A61K36/67 , A61K36/899 , A61K36/9068 , A61P25/22 , A61P37/04
摘要: The disclosure concerns methods for the inhibiting and treating of immune inflammation such as neuroinflammation, depression, anxiety, cognitive decline, nerve degeneration or the effect of aging, neurological disease, cognitive function, mental disorder, depression, anxiety disorders, stress, respiratory inflammation, post-nasal drip, sinus infections, chronic cough, infections, bacterial infection, viral infection, fungal infection, comprising administering a composition comprising a combination of herbal ingredients.
-
3.
公开(公告)号:US20240238358A1
公开(公告)日:2024-07-18
申请号:US18561963
申请日:2021-12-29
发明人: Boli Zhang , Junhua Zhang , Qingquan Liu , Fengwen Yang , Ming Huang , Yongming Guo , Xinbo Song , Han Zhang , Yuefei Wang , Yanxu Chang , Erwei Liu , Wenke Zheng
IPC分类号: A61K36/258 , A61K9/16 , A61K36/076 , A61K36/233 , A61K36/284 , A61K36/484 , A61K36/539 , A61K36/57 , A61K36/71 , A61K36/752 , A61K36/808 , A61K36/85 , A61K36/8888 , A61K36/8968 , A61K36/899 , A61K36/8994
CPC分类号: A61K36/258 , A61K9/1623 , A61K36/076 , A61K36/233 , A61K36/284 , A61K36/484 , A61K36/539 , A61K36/57 , A61K36/71 , A61K36/752 , A61K36/808 , A61K36/85 , A61K36/8888 , A61K36/8968 , A61K36/899 , A61K36/8994 , A61K2236/331
摘要: A traditional Chinese medicine composition for infectious disease recovery, containing the Chinese medicinal herbs: 2-4 parts of ginseng, 4-8 parts of Ophiopogon japonicus, 2-4 parts of Schisandra chinensis berry, 6-10 parts of Wolfiporia extensa Ginns, 6-10 parts of rhizoma pinelliae, 4-8 parts of Scrophularia ningpoensis, 4-6 parts of stir-fried Atractylodes, 4-8 parts of mandarin orange peel, 2-4 parts of Glycyrrhiza uralensis, 4-8 parts of Bupleurum scorzonerifolium, 2-4 parts of Actaea cimicifuga, 8-12 parts of Coix lacryma-jobi, 8-12 parts of Scutellaria baicalensis, 8-12 parts of Verbena officinalis, 12-18 parts of rhizoma phragmitis, and 1-3 parts of Lophatherum gracile. The present traditional Chinese medicine composition can be used in medicines for the prevention, treatment, or alleviation of the sequelae or complications of infectious diseases or for the promotion of the functional recovery of damaged tissues, organs or systems caused by infectious diseases.
-
公开(公告)号:US11969502B2
公开(公告)日:2024-04-30
申请号:US17183580
申请日:2021-02-24
发明人: Christopher Keller , Ronald K. Hutchens , Thomas H. Poole , Nicolas Von Cosmos , Anthony Richard Gerardi , Chris J. Grimes , Steven Lee Alderman , Darrell Eugene Holton, Jr. , Ross Jay Oden , Matthew Evan Lampe , Michael Andrew Zawadzki , Kristen Spielbauer
IPC分类号: A61K9/00 , A61K31/197 , A61K31/198 , A61K31/205 , A61K31/375 , A61K31/4415 , A61K31/522 , A61K31/7068 , A61K36/258 , A61K36/53 , A61K36/77 , A61K47/02 , A61K47/10 , A61K47/36 , A61K47/38
CPC分类号: A61K9/009 , A61K31/197 , A61K31/198 , A61K31/205 , A61K31/375 , A61K31/4415 , A61K31/522 , A61K31/7068 , A61K36/258 , A61K36/53 , A61K36/77 , A61K47/02 , A61K47/10 , A61K47/36 , A61K47/38
摘要: A composition configured for oral use is provided, the composition including a filler in an amount of at least 20% by weight, based on the total weight of the composition, and at least one active ingredient including one or more botanical materials, stimulants, amino acids, vitamins, antioxidants, cannabinoids, pharmaceutical agents, or a combination thereof. The composition further includes a salt and at least one sweetener. The composition has a moisture content of at least about 40% by weight, based on the total weight of the composition.
-
公开(公告)号:US20240091299A1
公开(公告)日:2024-03-21
申请号:US17947012
申请日:2022-09-16
申请人: The Hidden Vault LLC
发明人: Temeka Jones
IPC分类号: A61K36/9068 , A61K9/00 , A61K31/05 , A61K36/068 , A61K36/185 , A61K36/258 , A61K36/31 , A61K36/41 , A61K36/63 , A61K36/746 , A61K36/79 , A61K36/82 , A61K36/8962
CPC分类号: A61K36/9068 , A61K9/0034 , A61K31/05 , A61K36/068 , A61K36/185 , A61K36/258 , A61K36/31 , A61K36/41 , A61K36/63 , A61K36/746 , A61K36/79 , A61K36/82 , A61K36/8962
摘要: The present invention provides compositions formulated for topical administration to a penis of a person to enhance sexual responsiveness in the person, to enhance sexual performance, erection and stamina, and to increase the physical size of the penis, where the compositions comprise active components from herbal or plant origin including maca, tongkat ali, cordyceps, ginseng, fructus schisandrae. morinda root, rhodiola, rosea cordyceps sinensis, ginger, jasmine, sandalwood, leeks, camellia seed, jojoba oil and cannabidiol. The preferred composition is in the form of a massage oil, to be applied topically to the skin of the penis.
-
6.
公开(公告)号:US20240058408A1
公开(公告)日:2024-02-22
申请号:US18270687
申请日:2021-12-14
发明人: Sang Jun LEE , Se Young CHUNG
IPC分类号: A61K36/258 , A61K31/704 , A61P27/02
CPC分类号: A61K36/258 , A61K31/704 , A61P27/02 , A61K2236/331
摘要: A method for preventing or treating a macular degeneration disease, comprising administering a composition comprising a ginseng berry extract to a subject in need thereof. Since the composition can inhibit AE2 accumulation in retinal pigment epithelial cells, inhibit photooxidation, and inhibit outer nuclear layer damage of visual cells, it can be usefully used in preventing or treating macular degeneration disease.
-
7.
公开(公告)号:US20230346866A1
公开(公告)日:2023-11-02
申请号:US17912633
申请日:2021-03-19
发明人: Rachel ALKALAY
IPC分类号: A61K36/53 , A61K36/258 , A61K36/324 , A61K36/424 , A61K36/71 , A61K36/738 , A61K36/85 , A61K38/48 , A61P31/14
CPC分类号: A61K36/53 , A61K36/258 , A61K36/324 , A61K36/424 , A61K36/71 , A61K36/738 , A61K36/85 , A61K38/4873 , A61P31/14
摘要: A method of preventing or treating non-malignant respiratory disease (NMRD) in a subject in need thereof is provided. The method comprising administering to the subject an effective amount of a plant species or genus thereof-derived component selected from the group consisting of a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein the component is capable of ameliorating symptoms of NMRD and wherein the plant species is selected from the group consisting of Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum, Rhus coriaria, Gynostemma polyphyllum, Boswellia sacra and Panax ginseng preventing or treating NMRD in the subject.
-
8.
公开(公告)号:US11793838B2
公开(公告)日:2023-10-24
申请号:US17320194
申请日:2021-05-13
发明人: Jinchang Ai , Wu Tang
IPC分类号: A61K35/62 , A61K36/258 , A61K36/537 , A61K36/236 , A61K36/8988 , A61P9/10 , A61K36/88 , A61K36/28 , A61K36/16 , A61K36/484 , A61K36/734
CPC分类号: A61K35/62 , A61K36/16 , A61K36/236 , A61K36/258 , A61K36/28 , A61K36/484 , A61K36/537 , A61K36/734 , A61K36/88 , A61K36/8988 , A61P9/10
摘要: The present disclosure provides a traditional Chinese medicine (TCM) composition for the treatment of cardiovascular and cerebrovascular diseases and use thereof, and belongs to the technical field of TCM. The composition for the treatment of cardiovascular and cerebrovascular diseases provided by the present disclosure includes the following raw materials: Radix Panacis Quinquefolii, Pheretima, Radix et Rhizoma Salviae Miltiorrhizae, Hirudo, Rhizoma Ligustici Chuanxiong, Rhizoma Gastrodiae, Fructus Crataegi, Stigma Croci, Herba Erigerontis, Semen Ginkgo, and Radix et Rhizoma Glycyrrhizae. The present disclosure treats the cardiovascular and cerebrovascular diseases through treatment based on syndrome differentiation and overall regulation in TCM; with less side effects, excellent efficacy, and fast acting, the present disclosure can achieve a stenting-free effect on the cardiovascular and cerebrovascular diseases.
-
公开(公告)号:US11752183B2
公开(公告)日:2023-09-12
申请号:US16499990
申请日:2018-04-03
申请人: TCI CO., LTD
发明人: Yung-Hsiang Lin , I-Hui Chen , Kai-Wen Kan , Fu Chen Liu , Ciao-Ting Chen
IPC分类号: A61K36/185 , A23L33/105 , A61K9/00 , A61K9/08 , A61K9/48 , A61P3/04 , A61K31/01 , A61K31/015 , A61K36/21 , A61K36/258 , A61K36/31 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/67 , A61K36/73 , A61K36/74 , A61K36/752 , A61K36/815 , A61K36/82 , A61K36/87 , A61K36/886 , A61K36/8962 , A61K36/9066 , A61K8/9789 , A61P17/16 , A61Q19/00 , A23F3/16 , A61K8/97 , A61Q17/04 , A61P19/04 , A61Q19/08
CPC分类号: A61K36/185 , A23F3/163 , A23L33/105 , A61K8/97 , A61K8/9789 , A61K9/0056 , A61K9/0095 , A61K9/08 , A61K9/48 , A61K31/01 , A61K31/015 , A61K36/21 , A61K36/258 , A61K36/31 , A61K36/45 , A61K36/48 , A61K36/53 , A61K36/67 , A61K36/73 , A61K36/74 , A61K36/752 , A61K36/815 , A61K36/82 , A61K36/87 , A61K36/886 , A61K36/8962 , A61K36/9066 , A61P3/04 , A61P17/16 , A61P19/04 , A61Q17/04 , A61Q19/007 , A61Q19/08 , A23V2002/00
摘要: Provided is a plant extract-containing composition for reducing skin damage caused by ultraviolet radiation. The composition includes a combination of extracts of spinach, black tea, green tea, Pu-erh tea, Four Seasons Spring tea, red wine, blueberry, grape seeds, citrus, or green coffee beans.
-
公开(公告)号:US20230270711A1
公开(公告)日:2023-08-31
申请号:US17767633
申请日:2020-10-08
申请人: Zobrius Pharma AS
发明人: Bjørn Tore LANGELAND , Jan KARLSEN
IPC分类号: A61K31/26 , A61K36/258 , A61K36/9068 , A61K36/254 , A61K45/06 , A23L33/105 , A61P25/32 , A61K9/00 , A61K31/191 , A61K31/522 , A61K36/77 , A61K31/7004
CPC分类号: A61K31/26 , A61K36/258 , A61K36/9068 , A61K36/254 , A61K45/06 , A23L33/105 , A61P25/32 , A61K9/0095 , A61K31/191 , A61K31/522 , A61K36/77 , A61K31/7004
摘要: A composition for the promotion of alcohol and acetaldehyde degradation in a human is disclosed. The composition, which can be prepared by bringing all the ingredients together in intimate physical admixture, comprises an anti-hangover effective amount of:
(a) essential herbs consisting of Ilex paraguarensis (Yerba mate), Eleutherococcus senticosus (Siberian ginseng), Panax ginseng and Zingiberis officinalis (ginger); and
(b) one or more electrolyte(s) and, optionally,
(c) sulphoraphane.
Preferably, the composition is in the form of a low-volume, aqueous, after-alcohol drink, that can avoid some of the potentially adverse effects of previously-known anti-hangover preparations.
-
-
-
-
-
-
-
-
-